Crossmark

Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial

Crossref DOI link: https://doi.org/10.1136/bmjresp-2022-001236

Published Online: 2022-05-09

Published Print: 2022-05

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Chang, Anne B https://orcid.org/0000-0002-1331-3706
Morgan, Lucy C

Duncan, Emma L

Chatfield, Mark D

Schultz, André

Leo, Paul J

McCallum, Gabrielle B

McInerney-Leo, Aideen M

McPhail, Steven M

Zhao, Yuejen

Kruljac, Catherine

Smith-Vaughan, Heidi C

Morris, Peter S

Marchant, Julie M

Yerkovich, Stephanie T

Cook, Anne L

Wurzel, Danielle

Versteegh, Lesley

O’Farrell, Hannah

McElrea, Margaret S https://orcid.org/0000-0001-9078-2357
Fletcher, Sabine

D'Antoine, Heather

Stroil-Salama, Enna

Robinson, Phil J

Grimwood, Keith
Funding

Funding for this research was provided by:

MRFF/NHMRC (1169868)

NHMRC Centre for Research Excellence (1169868)

NHMRC Centre for Research Excellence (1170958)

NHMRC (1154302)

NHMRC (1158111)
License Information

License valid from 2022-05-09

Document is current

Any future updates will be listed below